{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:10:33Z","timestamp":1789661433068,"version":"4.0.1"},"publisher-location":"Berlin, Heidelberg","reference-count":113,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_356","type":"book-chapter","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:52:43Z","timestamp":1789660363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolving Cancer: Specialized Pro-resolving Mediators as Host-Directed Regulators of Tumor Progression and Therapy Response"],"prefix":"10.1007","author":[{"given":"Molly M.","family":"Gilligan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"5","key":"356_CR1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051532","volume":"19","author":"T Alkasalias","year":"2018","unstructured":"Alkasalias T et al (2018) Fibroblasts in the tumor microenvironment: shield or spear? Int J Mol Sci 19(5):1532","journal-title":"Int J Mol Sci"},{"issue":"41","key":"356_CR2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407130121","volume":"121","author":"MW Alnouri","year":"2024","unstructured":"Alnouri MW, Roquid KA, Bonnavion R (2024) SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor. Proc Natl Acad Sci USA 121(41):e2407130121","journal-title":"Proc Natl Acad Sci USA"},{"key":"356_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.acr.2016.11.002","volume":"134","author":"G Arentz","year":"2017","unstructured":"Arentz G, Mittal P, Zhang C (2017) Applications of mass spectrometry imaging to cancer. Adv Cancer Res 134:27\u201366","journal-title":"Adv Cancer Res"},{"issue":"12","key":"356_CR4","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.4049\/jimmunol.170.12.6266","volume":"170","author":"A Ariel","year":"2003","unstructured":"Ariel A et al (2003) Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 170(12):6266\u20136272","journal-title":"J Immunol"},{"key":"356_CR5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01298","volume":"10","author":"PF Asare","year":"2020","unstructured":"Asare PF et al (2020) LC3-associated phagocytosis (LAP): a potentially influential mediator of efferocytosis-related tumor progression and aggressiveness. Front Oncol 10:1298","journal-title":"Front Oncol"},{"key":"356_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.acr.2016.11.008","volume":"134","author":"B Balluff","year":"2017","unstructured":"Balluff B, Hanselmann M, Heeren RMA (2017) Mass spectrometry imaging for the investigation of intratumor heterogeneity. Adv Cancer Res 134:201\u2013230","journal-title":"Adv Cancer Res"},{"key":"356_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2025.08.003","volume":"86","author":"S Bhardwaj","year":"2025","unstructured":"Bhardwaj S, Gautam RK, Kushwaha S (2025) From senescence to scarring: exploring TGF-beta signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis. Cytokine Growth Factor Rev 86:29\u201339","journal-title":"Cytokine Growth Factor Rev"},{"key":"356_CR8","volume":"11","author":"W Blogowski","year":"2021","unstructured":"Blogowski W et al (2021) Lipoxins and resolvins in patients with pancreatic cancer: a preliminary report. Front Oncol 11:757073","journal-title":"Front Oncol"},{"issue":"1","key":"356_CR9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41419-025-08218-3","volume":"16","author":"L Brambilla","year":"2025","unstructured":"Brambilla L (2025) Neutrophil extracellular traps in cancer: immune modulation, therapy resistance, and the dilemma of targeting. Cell Death Dis 16(1):882","journal-title":"Cell Death Dis"},{"issue":"10","key":"356_CR10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29102233","volume":"29","author":"L Byrne","year":"2024","unstructured":"Byrne L, Guiry PJ (2024) Advances in the chemistry and biology of specialised pro-resolving mediators (SPMs). Molecules 29(10):2233","journal-title":"Molecules"},{"issue":"Pt 3","key":"356_CR11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.semcancer.2022.01.006","volume":"86","author":"X Cheng","year":"2022","unstructured":"Cheng X et al (2022) Surgery-mediated tumor-promoting effects on the immune microenvironment. Semin Cancer Biol 86(Pt 3):408\u2013419","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"356_CR12","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"L Cheng","year":"2024","unstructured":"Cheng L, Li Y, Liu Z (2024) CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nat Commun 15(1):2818","journal-title":"Nat Commun"},{"issue":"3","key":"356_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang N, Serhan CN (2020) Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 64(3):443\u2013462","journal-title":"Essays Biochem"},{"key":"356_CR14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.2021013422","volume":"139","author":"N Chiang","year":"2022","unstructured":"Chiang N, Sakuma M, Rodriguez AR, Spur BW, Irimia D, Serhan CN (2022) Resolvin T-series reduce neutrophil extracellular traps. Blood 139:1222\u20131233","journal-title":"Blood"},{"issue":"353","key":"356_CR15","doi-asserted-by":"crossref","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","volume":"8","author":"V Chiurchiu","year":"2016","unstructured":"Chiurchiu V, Leuti A, Dalli J (2016) Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med 8(353):353ra111","journal-title":"Sci Transl Med"},{"issue":"2","key":"356_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2018.08.061","volume":"175","author":"LD Cunha","year":"2018","unstructured":"Cunha LD, Yang M, Carter R (2018) LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance. Cell 175(2):429\u2013441.e16","journal-title":"Cell"},{"issue":"6","key":"356_CR17","volume":"4","author":"J Dalli","year":"2016","unstructured":"Dalli J, Serhan CN (2016) Lipid mediators in inflammation. Microbiol Spectr 4(6):MCHD-0035-2016","journal-title":"Microbiol Spectr"},{"issue":"7","key":"356_CR18","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","volume":"27","author":"J Dalli","year":"2013","unstructured":"Dalli J, Zhu M, Vlasenko NA (2013) The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J 27(7):2573\u20132583","journal-title":"FASEB J"},{"key":"356_CR19","volume":"9","author":"NM de-Brito","year":"2019","unstructured":"de-Brito NM et al (2019) Lipoxin-induced phenotypic changes in CD115+LY6Chi monocytes TAM precursors inhibits tumor development. Front Oncol 9:540","journal-title":"Front Oncol"},{"issue":"17","key":"356_CR20","volume":"13","author":"U Demkow","year":"2021","unstructured":"Demkow U (2021) Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancer 13(17):4495","journal-title":"Cancer"},{"key":"356_CR21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1470620","volume":"15","author":"J Dimitrov","year":"2024","unstructured":"Dimitrov J, Maddalena M, Terlizzi C (2024) Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells. Front Immunol 15:1470620","journal-title":"Front Immunol"},{"issue":"12","key":"356_CR22","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1535-7163.MCT-21-0414","volume":"20","author":"T Dong","year":"2021","unstructured":"Dong T, Dave P, Yoo E (2021) NAP1051, a lipoxin A4 biomimetic analogue, demonstrates antitumor activity against the tumor microenvironment. Mol Cancer Ther 20(12):2384\u20132397","journal-title":"Mol Cancer Ther"},{"key":"356_CR23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650\u20131659","journal-title":"N Engl J Med"},{"issue":"3","key":"356_CR24","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","volume":"217","author":"NG Frangogiannis","year":"2020","unstructured":"Frangogiannis NG (2020) Transforming growth factor-beta in tissue fibrosis. J Exp Med 217(3):e20190103","journal-title":"J Exp Med"},{"issue":"1","key":"356_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.13278","volume":"319","author":"G Fredman","year":"2023","unstructured":"Fredman G (2023) Specialized pro-resolving mediators enhance the clearance of dead cells. Immunol Rev 319(1):151\u2013157","journal-title":"Immunol Rev"},{"issue":"40","key":"356_CR26","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","volume":"111","author":"G Fredman","year":"2014","unstructured":"Fredman G, Ozcan L, Spolitu S (2014) Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proc Natl Acad Sci USA 111(40):14530\u201314535","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"356_CR27","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","volume":"116","author":"MM Gilligan","year":"2019","unstructured":"Gilligan MM, Gartung A, Sulciner ML (2019) Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proc Natl Acad Sci USA 116(13):6292\u20136297","journal-title":"Proc Natl Acad Sci USA"},{"key":"356_CR28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217468","volume":"612","author":"O Gilon-Zaltsman","year":"2025","unstructured":"Gilon-Zaltsman O, Weidenfeld-Barenboim K, Samara H (2025) Targeting dormant disseminated tumor cells and their permissive niche by pro-resolving mediators derived from resolution-phase macrophages. Cancer Lett 612:217468","journal-title":"Cancer Lett"},{"issue":"6","key":"356_CR29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221472","volume":"220","author":"MA Gonzalez","year":"2023","unstructured":"Gonzalez MA, Lu DR, Yousefi M (2023) Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. J Exp Med 220(6):e20221472","journal-title":"J Exp Med"},{"issue":"1","key":"356_CR30","volume":"442","author":"X Guan","year":"2024","unstructured":"Guan X et al (2024) NETs: important players in cancer progression and therapeutic resistance. Exp Cell Res 442(1):114243","journal-title":"Exp Cell Res"},{"key":"356_CR31","doi-asserted-by":"publisher","unstructured":"Gul-Utku O, Karatay E, Ergul B, Kisa U, Erdin Z, Oguz D (2020) The role of resolvin D1 in the differential diagnosis of the cholangiocarcinoma and benign biliary diseases. Clin Lab 66. https:\/\/doi.org\/10.7754\/Clin.Lab.2020.200212","DOI":"10.7754\/Clin.Lab.2020.200212"},{"key":"356_CR32","volume":"12","author":"Y Han","year":"2024","unstructured":"Han Y et al (2024) Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot. Front Cell Dev Biol 12:1363121","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"356_CR33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"5","key":"356_CR34","volume":"132","author":"BL Heckmann","year":"2019","unstructured":"Heckmann BL, Green DR (2019) LC3-associated phagocytosis at a glance. J Cell Sci 132(5):jcs222984","journal-title":"J Cell Sci"},{"issue":"4","key":"356_CR35","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2015.07.076","volume":"464","author":"BS Herrera","year":"2015","unstructured":"Herrera BS et al (2015) LXA4 actions direct fibroblast function and wound closure. Biochem Biophys Res Commun 464(4):1072\u20131077","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"356_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/imr.13277","volume":"321","author":"Z Hu","year":"2024","unstructured":"Hu Z, Wang H, Liu Y (2024) NETosis: sculpting tumor metastasis and immunotherapy. Immunol Rev 321(1):263\u2013279","journal-title":"Immunol Rev"},{"issue":"1","key":"356_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","volume":"25","author":"Z Huang","year":"2025","unstructured":"Huang Z, Chen J, Zhu T (2025) Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications. Mol Cancer 25(1):19","journal-title":"Mol Cancer"},{"key":"356_CR38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106726","volume":"166","author":"AS Kahnt","year":"2023","unstructured":"Kahnt AS, Schebb NH, Steinhilber D (2023) Formation of lipoxins and resolvins in human leukocytes. Prostaglandins Other Lipid Mediat 166:106726","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"356_CR39","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1002\/jcp.27165","volume":"234","author":"V Kain","year":"2019","unstructured":"Kain V, Halade GV (2019) Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment. J Cell Physiol 234(4):3910\u20133920","journal-title":"J Cell Physiol"},{"issue":"6","key":"356_CR40","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB et al (2023) Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res 29(6):1009\u20131016","journal-title":"Clin Cancer Res"},{"key":"356_CR41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106854","volume":"174","author":"Y Kiyasu","year":"2024","unstructured":"Kiyasu Y et al (2024) EPA, DHA, and resolvin effects on cancer risk: the underexplored mechanisms. Prostaglandins Other Lipid Mediat 174:106854","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"3","key":"356_CR42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-016-2467-x","volume":"365","author":"SE Kuzet","year":"2016","unstructured":"Kuzet SE, Gaggioli C (2016) Fibroblast activation in cancer: when seed fertilizes soil. Cell Tissue Res 365(3):607\u2013619","journal-title":"Cell Tissue Res"},{"key":"356_CR43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702785","volume":"12","author":"M Lavy","year":"2021","unstructured":"Lavy M et al (2021) Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities. Front Immunol 12:702785","journal-title":"Front Immunol"},{"issue":"1","key":"356_CR44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","volume":"216","author":"W Lee","year":"2019","unstructured":"Lee W et al (2019) Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum. J Exp Med 216(1):176\u2013194","journal-title":"J Exp Med"},{"issue":"5","key":"356_CR45","volume":"35","author":"HN Lee","year":"2021","unstructured":"Lee HN, Choi YS, Kim SH (2021) Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality. FASEB J 35(5):e21432","journal-title":"FASEB J"},{"issue":"1","key":"356_CR46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"W Lee","year":"2025","unstructured":"Lee W et al (2025a) Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell 43(1):69\u201385.e11","journal-title":"Cancer Cell"},{"key":"356_CR47","volume":"84","author":"TE Lee","year":"2025","unstructured":"Lee TE et al (2025b) Specialized pro-resolving mediators: biosynthetic pathways, biocatalytic synthesis, and applications. Biotechnol Adv 84:108682","journal-title":"Biotechnol Adv"},{"issue":"1","key":"356_CR48","volume":"23","author":"N Li","year":"2025","unstructured":"Li N, Yang S, Hu C (2025) Neutrophil extracellular traps regulate LDHA expression to promote colorectal cancer liver metastasis. J Transl Med 23(1):1208","journal-title":"J Transl Med"},{"issue":"1","key":"356_CR49","volume":"136","author":"H Li","year":"2026","unstructured":"Li H, Zhang Y, Lin J (2026) Tumor-derived neutrophil extracellular trap-associated DNA impairs treatment efficacy in breast cancer via CCDC25-dependent epithelial-mesenchymal transition. J Clin Invest 136(1):e190557","journal-title":"J Clin Invest"},{"issue":"14","key":"356_CR50","volume":"14","author":"F Liotti","year":"2022","unstructured":"Liotti F et al (2022) The impact of resolution of inflammation on tumor microenvironment: exploring new ways to control cancer progression. Cancer 14(14):3333","journal-title":"Cancer"},{"issue":"46","key":"356_CR51","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1073\/pnas.1907490116","volume":"116","author":"Y Liu","year":"2019","unstructured":"Liu Y (2019) HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc Natl Acad Sci USA 116(46):23254\u201323263","journal-title":"Proc Natl Acad Sci USA"},{"key":"356_CR52","doi-asserted-by":"crossref","first-page":"31077","DOI":"10.1021\/acsnano.5c09460","volume":"19","author":"Y Liu","year":"2025","unstructured":"Liu Y (2025) Reprogramming macrophage via an antigen phagocytosis-presentation nanoenhancer for improved cancer immunotherapy. ACS Nano 19:31077","journal-title":"ACS Nano"},{"issue":"1","key":"356_CR53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","volume":"24","author":"YT Liu","year":"2025","unstructured":"Liu YT, Wang YL, Wang S (2025a) Turning cold tumors into hot tumors to ignite immunotherapy. Mol Cancer 24(1):254","journal-title":"Mol Cancer"},{"issue":"8","key":"356_CR54","volume":"135","author":"K Liu","year":"2025","unstructured":"Liu K, Zhang Y, Du G (2025b) 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. J Clin Invest 135(8):e183544","journal-title":"J Clin Invest"},{"key":"356_CR55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1655019","volume":"16","author":"M Maddalena","year":"2025","unstructured":"Maddalena M, Dimitrov J, Mehmood T (2025) Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells. Front Immunol 16:1655019","journal-title":"Front Immunol"},{"key":"356_CR56","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.jid.2025.04.015","volume":"145","author":"C Malactou","year":"2025","unstructured":"Malactou C, Hayes M, Zhang T, Ward S, Harwood C, Dalli J, Strid J (2025) Eosinophils and bioactive lipid mediators regulate skin inflammation and cancer growth. J Invest Dermatol 145:3064\u20133078.e7","journal-title":"J Invest Dermatol"},{"key":"356_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2021.03.023","volume":"78","author":"SH Manjili","year":"2022","unstructured":"Manjili SH et al (2022) Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse. Semin Cancer Biol 78:17\u201322","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"356_CR58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE et al (2019) Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med 380(1):23\u201332","journal-title":"N Engl J Med"},{"issue":"20","key":"356_CR59","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2174\/1389557520666200719014433","volume":"20","author":"M Mastromarino","year":"2020","unstructured":"Mastromarino M et al (2020) G-protein coupled receptors involved in the resolution of inflammation: ligands and therapeutic perspectives. Mini Rev Med Chem 20(20):2090\u20132103","journal-title":"Mini Rev Med Chem"},{"key":"356_CR60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13046-021-01937-3","volume":"40","author":"D Mattoscio","year":"2021","unstructured":"Mattoscio D, Isopi E, Lamolinara A, Patruno S, Medda A, De Cecco F, Chiocca S, Iezzi M, Romano M, Recchiuti A (2021) Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes. J Exp Clin Cancer Res 40:129","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"356_CR61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126473","volume":"23","author":"D Mattoscio","year":"2022","unstructured":"Mattoscio D et al (2022) Gene expression of the D-series resolvin pathway predicts activation of anti-tumor immunity and clinical outcomes in head and neck cancer. Int J Mol Sci 23(12):6473","journal-title":"Int J Mol Sci"},{"issue":"4","key":"356_CR62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/molpharm.121.000422","volume":"101","author":"J Merlin","year":"2022","unstructured":"Merlin J, Park J, Vandekolk TH (2022) Multipathway in vitro pharmacological characterization of specialized proresolving G protein-coupled receptors. Mol Pharmacol 101(4):246\u2013256","journal-title":"Mol Pharmacol"},{"issue":"1","key":"356_CR63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12944-024-02386-5","volume":"23","author":"A Molfino","year":"2024","unstructured":"Molfino A, Imbimbo G, Salerno G (2024) Assessment of plasma resolvin levels in women with breast cancer and their associations with disease presentation and immunohistochemical characteristics. Lipids Health Dis 23(1):396","journal-title":"Lipids Health Dis"},{"issue":"10","key":"356_CR64","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/cancers17101694","volume":"17","author":"A Molfino","year":"2025","unstructured":"Molfino A, Imbimbo G, Salerno G (2025) Effects of DHA oral supplementation on plasma resolvin D1 and D2 levels in naive breast cancer patients. Cancer 17(10):1694","journal-title":"Cancer"},{"issue":"18","key":"356_CR65","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.jacc.2018.08.2147","volume":"72","author":"KJ Moore","year":"2018","unstructured":"Moore KJ, Koplev S, Fisher EA (2018) Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (Part 2). J Am Coll Cardiol 72(18):2181\u20132197","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"356_CR66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.clbc.2025.09.003","volume":"25","author":"S Moradpanah","year":"2025","unstructured":"Moradpanah S, Forouzin S, Samadi F (2025) The unseen enemies: harnessing the role of neutrophil extracellular traps in breast cancer progression, immune evasion, and treatment resistance. Clin Breast Cancer 25(8):721\u2013731","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"356_CR67","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","volume":"41","author":"A Mousset","year":"2023","unstructured":"Mousset A, Lecorgne E, Bourget I (2023) Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-beta activation. Cancer Cell 41(4):757\u2013775.e10","journal-title":"Cancer Cell"},{"issue":"10","key":"356_CR68","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamaoncol.2023.2174","volume":"9","author":"A Necchi","year":"2023","unstructured":"Necchi A, Faltas BM, Slovin SF (2023) Immunotherapy in the treatment of localized genitourinary cancers. JAMA Oncol 9(10):1447\u20131454","journal-title":"JAMA Oncol"},{"issue":"18","key":"356_CR69","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-12-1087","volume":"18","author":"E Neeman","year":"2012","unstructured":"Neeman E, Zmora O, Ben-Eliyahu S (2012) A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin Cancer Res 18(18):4895\u20134902","journal-title":"Clin Cancer Res"},{"issue":"9","key":"356_CR70","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","volume":"21","author":"M Ochoa de Olza","year":"2020","unstructured":"Ochoa de Olza M et al (2020) Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol 21(9):e419\u2013e430","journal-title":"Lancet Oncol"},{"key":"356_CR71","volume":"15","author":"P Ouyang","year":"2024","unstructured":"Ouyang P, Wang L, Wu J (2024) Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors. Front Immunol 15:1344272","journal-title":"Front Immunol"},{"issue":"5","key":"356_CR72","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s10753-022-01666-5","volume":"45","author":"WH Pan","year":"2022","unstructured":"Pan WH et al (2022) The effect and mechanism of lipoxin A4 on neutrophil function in LPS-induced lung injury. Inflammation 45(5):1950\u20131967","journal-title":"Inflammation"},{"issue":"7","key":"356_CR73","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1172\/JCI127282","volume":"129","author":"D Panigrahy","year":"2019","unstructured":"Panigrahy D, Gartung A, Yang J (2019) Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. J Clin Invest 129(7):2964\u20132979","journal-title":"J Clin Invest"},{"key":"356_CR74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","volume":"227","author":"D Panigrahy","year":"2021","unstructured":"Panigrahy D et al (2021) Resolution of inflammation: an organizing principle in biology and medicine. Pharmacol Ther 227:107879","journal-title":"Pharmacol Ther"},{"key":"356_CR75","volume":"98","author":"C Paraskeva","year":"2025","unstructured":"Paraskeva C, Stavropoulou A, Koliaraki V (2025) Cancer-associated fibroblasts: recent advances and therapeutic implications. Curr Opin Cell Biol 98:102601","journal-title":"Curr Opin Cell Biol"},{"key":"356_CR76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768133","volume":"12","author":"J Perez-Hernandez","year":"2021","unstructured":"Perez-Hernandez J et al (2021) Regulation of T-cell immune responses by pro-resolving lipid mediators. Front Immunol 12:768133","journal-title":"Front Immunol"},{"issue":"4","key":"356_CR77","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1213\/ANE.0000000000007328","volume":"140","author":"NJS Perry","year":"2025","unstructured":"Perry NJS, Jhanji S, Poulogiannis G (2025) Cancer biology and the perioperative period: opportunities for disease evolution and challenges for perioperative care. Anesth Analg 140(4):846\u2013859","journal-title":"Anesth Analg"},{"issue":"2","key":"356_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward MK, Weaver VM (2020) Fibrosis and cancer: a strained relationship. Biochim Biophys Acta Rev Cancer 1873(2):188356","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"356_CR79","volume":"167","author":"H Qiu","year":"2023","unstructured":"Qiu H, Shao Z, Wen X (2023) Efferocytosis: an accomplice of cancer immune escape. Biomed Pharmacother 167:115540","journal-title":"Biomed Pharmacother"},{"key":"356_CR80","volume":"176","author":"VH Quinlivan","year":"2025","unstructured":"Quinlivan VH, Howard IV, Southan F (2025) Exploring the unique role of specialized pro-resolving mediators in cancer therapeutics. Prostaglandins Other Lipid Mediat 176:106944","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"356_CR81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molmed.2023.03.002","volume":"29","author":"R Rebelo","year":"2023","unstructured":"Rebelo R et al (2023) Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med 29(6):439\u2013453","journal-title":"Trends Mol Med"},{"key":"356_CR82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/7651_2017_44","volume":"1697","author":"GM Reynolds","year":"2017","unstructured":"Reynolds GM, Visentin B, Sabbadini R (2017) Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples and cell lines. Methods Mol Biol 1697:43\u201356","journal-title":"Methods Mol Biol"},{"issue":"1","key":"356_CR83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cncr.31594","volume":"125","author":"I Ricon","year":"2019","unstructured":"Ricon I et al (2019) Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of beta-adrenergic and cyclooxygenase 2 signaling. Cancer 125(1):45\u201356","journal-title":"Cancer"},{"key":"356_CR84","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","volume":"13","author":"NH Schebb","year":"2022","unstructured":"Schebb NH, Kuhn H, Kahnt AS (2022) Formation, signaling and occurrence of specialized pro-resolving lipid mediators \u2013 what is the evidence so far? Front Pharmacol 13:838782","journal-title":"Front Pharmacol"},{"issue":"7503","key":"356_CR85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510(7503):92\u2013101","journal-title":"Nature"},{"key":"356_CR86","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","volume":"81","author":"CN Serhan","year":"1984","unstructured":"Serhan CN, Hamberg M, Samuelsson B (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 81:5335\u20135339","journal-title":"Proc Natl Acad Sci USA"},{"key":"356_CR87","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:1025\u20131037","journal-title":"J Exp Med"},{"key":"356_CR88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","volume":"206","author":"CN Serhan","year":"2009","unstructured":"Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206:15\u201323","journal-title":"J Exp Med"},{"key":"356_CR89","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","volume":"59","author":"CN Serhan","year":"2022","unstructured":"Serhan CN, Libreros S, Nshimiyimana R (2022) E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Semin Immunol 59:101597","journal-title":"Semin Immunol"},{"issue":"2","key":"356_CR90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-025-00888-7","volume":"26","author":"MH Shahzad","year":"2025","unstructured":"Shahzad MH et al (2025) Neutrophil extracellular traps in cancer. Nat Rev Cancer 26(2):104\u2013117","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"356_CR91","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1111\/jcmm.15436","volume":"24","author":"K Shan","year":"2020","unstructured":"Shan K, Feng N, Cui J (2020) Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization. J Cell Mol Med 24(14):8045\u20138056","journal-title":"J Cell Mol Med"},{"issue":"2","key":"356_CR92","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.30424","volume":"140","author":"RL Simoes","year":"2017","unstructured":"Simoes RL et al (2017) Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression. Int J Cancer 140(2):346\u2013357","journal-title":"Int J Cancer"},{"issue":"1","key":"356_CR93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.20170681","volume":"215","author":"ML Sulciner","year":"2018","unstructured":"Sulciner ML, Serhan CN, Gilligan MM (2018) Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med 215(1):115\u2013140","journal-title":"J Exp Med"},{"key":"356_CR94","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108460","volume":"247","author":"TH Thatcher","year":"2023","unstructured":"Thatcher TH et al (2023) Is there a role for specialized pro-resolving mediators in pulmonary fibrosis? Pharmacol Ther 247:108460","journal-title":"Pharmacol Ther"},{"key":"356_CR95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.prostaglandins.2017.01.002","volume":"132","author":"R Tian","year":"2017","unstructured":"Tian R et al (2017) ALOX15 as a suppressor of inflammation and cancer: lost in the link. Prostaglandins Other Lipid Mediat 132:77\u201383","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"7","key":"356_CR96","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","volume":"77","author":"S Tohme","year":"2017","unstructured":"Tohme S, Simmons RL, Tsung A (2017) Surgery for cancer: a trigger for metastases. Cancer Res 77(7):1548\u20131552","journal-title":"Cancer Res"},{"issue":"8","key":"356_CR97","volume":"12","author":"F Ungaro","year":"2020","unstructured":"Ungaro F, D\u2019Alessio S, Danese S (2020) The role of pro-resolving lipid mediators in colorectal cancer-associated inflammation: implications for therapeutic strategies. Cancer 12(8):2060","journal-title":"Cancer"},{"issue":"13","key":"356_CR98","volume":"13","author":"A Vannitamby","year":"2021","unstructured":"Vannitamby A, Saad MI, Aloe C (2021) Aspirin-triggered resolvin D1 reduces proliferation and the neutrophil to lymphocyte ratio in a mutant KRAS-driven lung adenocarcinoma model. Cancer 13(13):3224","journal-title":"Cancer"},{"issue":"3","key":"356_CR99","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tibs.2018.10.007","volume":"44","author":"J Wei","year":"2019","unstructured":"Wei J, Gronert K (2019) Eicosanoid and specialized proresolving mediator regulation of lymphoid cells. Trends Biochem Sci 44(3):214\u2013225","journal-title":"Trends Biochem Sci"},{"key":"356_CR100","volume":"220","author":"N Wei","year":"2025","unstructured":"Wei N et al (2025) Lipoxin A4 suppresses neutrophil extracellular traps formation through the FPR2-dependent regulation of METTL3 in ischemic stroke. Brain Res Bull 220:111178","journal-title":"Brain Res Bull"},{"issue":"6","key":"356_CR101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","volume":"40","author":"TA Werfel","year":"2018","unstructured":"Werfel TA, Cook RS (2018) Efferocytosis in the tumor microenvironment. Semin Immunopathol 40(6):545\u2013554","journal-title":"Semin Immunopathol"},{"issue":"1","key":"356_CR102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1158\/0008-5472.CAN-18-1106","volume":"79","author":"TA Werfel","year":"2019","unstructured":"Werfel TA, Elion DL, Rahman B (2019) Treatment-induced tumor cell apoptosis and secondary necrosis drive tumor progression in the residual tumor microenvironment through MerTK and IDO1. Cancer Res 79(1):171\u2013182","journal-title":"Cancer Res"},{"key":"356_CR103","volume":"12","author":"A Wetzel","year":"2021","unstructured":"Wetzel A, Bonnefoy F, Chague C (2021) Pro-resolving factor administration limits cancer progression by enhancing immune response against cancer cells. Front Immunol 12:812171","journal-title":"Front Immunol"},{"issue":"1","key":"356_CR104","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B et al (2024) Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther 9(1):274","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"356_CR105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI93554","volume":"128","author":"M Yamauchi","year":"2018","unstructured":"Yamauchi M et al (2018) The fibrotic tumor stroma. J Clin Invest 128(1):16\u201325","journal-title":"J Clin Invest"},{"key":"356_CR106","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Huang L, Liu Y (2023) Chronic inflammation, immune suppression, and tumor microenvironment. Front Immunol 14:1185048","journal-title":"Front Immunol"},{"issue":"7814","key":"356_CR107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang L, Liu Q, Zhang X (2020) DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 583(7814):133\u2013138","journal-title":"Nature"},{"issue":"1","key":"356_CR108","doi-asserted-by":"crossref","first-page":"18849","DOI":"10.1038\/s41598-020-76005-5","volume":"10","author":"JJ Yi","year":"2020","unstructured":"Yi JJ, Heo SY, Ju JH (2020) Synthesis of two new lipid mediators from docosahexaenoic acid by combinatorial catalysis involving enzymatic and chemical reaction. Sci Rep 10(1):18849","journal-title":"Sci Rep"},{"issue":"12","key":"356_CR109","volume":"7","author":"C Yin","year":"2016","unstructured":"Yin C et al (2016) Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis. Cell Death Dis 7(12):e2529","journal-title":"Cell Death Dis"},{"issue":"1","key":"356_CR110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","volume":"39","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ (2020) Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res 39(1):112","journal-title":"J Exp Clin Cancer Res"},{"key":"356_CR111","doi-asserted-by":"crossref","first-page":"e198815","DOI":"10.1172\/JCI198815","volume":"136","author":"L Yu","year":"2026","unstructured":"Yu L, Rivas C, Liu F, Shen Y, Wu L, Xu Z, Ding Y, Hao X, Zhang W, Chan HL, Liu J, Wei B, Gao Y, Becerra-Dominguez L, Wu YH, Wang S, Lee TD, Li X, Chen X, Edwards DG, Zhang XH (2026) Inflammation- and resolution-programmed myeloid circuits govern therapeutic resistance in epithelial and mesenchymal triple-negative breast cancer. J Clin Invest 136:e198815","journal-title":"J Clin Invest"},{"key":"356_CR112","volume":"168","author":"YL Zhang","year":"2025","unstructured":"Zhang YL, Zang HJ, Wen QY (2025) Macrophage polarization in tumors: the impact of efferocytosis. Int Immunopharmacol 168:115807","journal-title":"Int Immunopharmacol"},{"key":"356_CR113","volume":"19","author":"X Zuo","year":"2025","unstructured":"Zuo X, Kiyasu Y, Liu Y, Deguchi Y, Liu F, Moussalli M, Tan L, Wei B, Wei D, Yang P, Shureiqi I (2025) Colorectal 15-lipoxygenase-1 as a host factor determining the effects of eicosapentaenoic acid and docosahexaenoic acid on colorectal tumorigenesis in mice. Cell Mol Gastroenterol Hepatol 19:101607","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:52:59Z","timestamp":1789660379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":113,"URL":"https:\/\/doi.org\/10.1007\/82_2026_356","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"18 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The author(s) has no competing interests to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declares that this chapter does not include primary research with human participants.The author(s) declares that this chapter does not include primary studies involving animals.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}